Antivirals Reactions 1680, p50 - 2 Dec 2017 Virological failure and acquired multi-antiviral resistance to HIV-1C infection: 26 case reports In a prospective cohort study of 320 patients, 15 women and 11 men aged between 25–51 years were described, who developed virological failure and acquired multi-antiviral resistance to antivirals during treatment of HIV-1C infection [routes and dosages not stated]. The patients, who had a history of HIV-1C infection, started receiving treatment with lamivudine, stavudine and nevirapine (9 patients), lamivudine, stavudine and efavirenz (1 patient), lamivudine, zidovudine and nevirapine (12 patients) and lamivudine, zidovudine and efavirenz (4 patients). After 5–8 years of antiviral treatments, the patients developed virological failure and acquired multi-antiviral drug resistance mutations, which were confirmed by genotypic susceptibility test [outcomes not stated]. Author comment: "This study describes a decade virological outcomes and measures the incidence of virological failure and acquired drug resistance mutations in Ethiopian HIV-1C infected adults at 4 time points from the Horn of Africa." Mulu A, et al. Upward trends of acquired drug resistances in Ethiopian HIV-1C isolates: A decade longitudinal study. PLOS One 12: e0186619, No. 10, Oct 2017. Available from: URL: - Ethiopia 803284108 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 Reactions Weekly Springer Journals


Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site


You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial